|
|
Volumn 28, Issue 2, 2002, Pages 78-80
|
|
Observational series on women using the contraceptive Mirena® concurrently with anti-epileptic and other enzyme-inducing drugs
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
AMITRIPTYLINE;
ANTICONVULSIVE AGENT;
CARBAMAZEPINE;
CARBIMAZOLE;
CLOBAZAM;
DICLOFENAC;
EFAVIRENZ;
ENZYME INDUCING AGENT;
GABAPENTIN;
LAMIVUDINE PLUS ZIDOVUDINE;
LAMOTRIGINE;
LEVONORGESTREL;
LITHIUM CITRATE;
NEFOPAM;
NEVIRAPINE;
PHENOBARBITAL;
PHENYTOIN;
PRIMIDONE;
RIFABUTIN;
RITONAVIR;
TOPIRAMATE;
TRIMIPRAMINE;
VALPROIC ACID;
VIGABATRIN;
ENZYME ACTIVATOR;
ADOLESCENT;
ADULT;
ARTICLE;
COMORBIDITY;
CONTRACEPTION;
DRUG ANTAGONISM;
DRUG EFFICACY;
ENZYME INDUCTION;
EPILEPSY;
FEMALE;
FOLLOW UP;
HUMAN;
INTRAUTERINE CONTRACEPTIVE DEVICE;
MAJOR CLINICAL STUDY;
PATIENT MONITORING;
PATIENT SELECTION;
PREGNANCY RATE;
RISK FACTOR;
TERATOGENICITY;
TREATMENT FAILURE;
PILOT STUDY;
PREGNANCY;
UNITED KINGDOM;
ADULT;
ANTICONVULSANTS;
ENZYME ACTIVATORS;
FEMALE;
FOLLOW-UP STUDIES;
GREAT BRITAIN;
HUMAN;
INTRAUTERINE DEVICES, MEDICATED;
PILOT PROJECTS;
PREGNANCY;
PREGNANCY RATE;
SUPPORT, NON-U.S. GOV'T;
HUMANS;
|
|
EID: 0036015726
PISSN: 14711893
EISSN: None
Source Type: Journal
DOI: 10.1783/147118902101195992 Document Type: Article |
|
Times cited : (69)
|
|
References (10)
|
